Literature DB >> 7706728

Transcription of the TCR-beta locus initiates in adult murine bone marrow.

R S Soloff1, T G Wang, L Lybarger, D Dempsey, R Chervenak.   

Abstract

Successful expression of the TCR beta-chain gene is a multistep process that involves: 1) initial transcription of multiple, unrearranged gene segments, 2) rearrangement of V, D, and J gene segments to form a complete beta-chain gene, and 3) transcription of the fully rearranged beta gene. All of these events have been shown to occur in the thymus, where the majority of T cell development takes place; however, the extent to which any of these events may occur prethymically has not been established. To examine prethymic TCR-beta gene expression, RNA was isolated from a precursor T cell-enriched population (Thy 1low CD3-) of C58/J mouse bone marrow, and analyzed by reverse transcriptase-PCR. A transcript containing TCR-beta constant (C) region sequences but not variable (V) region sequences was amplified, suggesting that an unrearranged TCR-beta gene locus is transcriptionally active in this bone marrow population. The same product was detected in Thy 1+ CD3- bone marrow cells from nude mice, indicating that the thymic microenvironment is not necessary for initiation of TCR-beta gene transcription. This C beta transcript is not confined to pre-B cells, as it was identified in RNA isolated from Thy 1low CD3- B220- bone marrow cells. Germline V beta transcripts were also detected in RNA from this bone marrow population. Furthermore, Sca-1+ Lin- and Sca-1+ Lin+ bone marrow populations from both C58/J mice and nude mice also expressed the C beta transcript. DNA-PCR analyses with D beta-J beta primer sets revealed that partial rearrangement of the beta locus had occurred in all bone marrow populations analyzed. These data suggest that both transcription and partial rearrangement of the TCR-beta locus can initiate in bone marrow cells of adult mice, before exposure of these cells to the thymus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Distal V beta promoters transcribe novel T-cell receptor-beta transcripts in early development.

Authors:  K A Sutton; M N Vu; M F Wilkinson
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia.

Authors:  Colleen J Winstead; Cavan S Reilly; James J Moon; Marc K Jenkins; Sara E Hamilton; Stephen C Jameson; Sing Sing Way; Alexander Khoruts
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

3.  Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior.

Authors:  Mineui Hong; Taehee Lee; So Young Kang; Suk-Jin Kim; Wonseog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

4.  Cross-lineage expression of Ig-beta (B29) in thymocytes: positive and negative gene regulation to establish T cell identity.

Authors:  H Wang; R A Diamond; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

5.  Irradiation-mediated rescue of T cell-specific V(D)J recombination and thymocyte differentiation in severe combined immunodeficient mice by bone marrow cells.

Authors:  C Wang; M A Bogue; J M Levitt; D B Roth
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

6.  Identification of a committed T cell precursor population in adult human peripheral blood.

Authors:  L Bruno; P Res; M Dessing; M Cella; H Spits
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

7.  Ancient T-independence of mucosal IgX/A: gut microbiota unaffected by larval thymectomy in Xenopus laevis.

Authors:  S Mashoof; A Goodroe; C C Du; J O Eubanks; N Jacobs; J M Steiner; I Tizard; J S Suchodolski; M F Criscitiello
Journal:  Mucosal Immunol       Date:  2012-08-29       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.